MICHAEL PEQUENO: Open Payments
NPI 1467944256 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,453 in 50 payments from 15 companies in 2025. Trend: 2023 $644 · 2024 $679 · 2025 $2,453
Food & beverage: $1,433Travel & lodging: $1,020
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 17 | $1,485 |
| Medtronic, Inc. | 2 | $278 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $162 |
| SCPHARMACEUTICALS INC. | 2 | $152 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| ABIOMED | 2 | $54 |
| Merck Sharp & Dohme LLC | 3 | $45 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $45 |
| AtriCure, Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
Products named: Barostim Neo System, Kerendia, SYMPLICITY G3, FUROSCIX, ENDURANT IIS, SHINGRIX, VERQUVO, LifeVest.
Industry payments across TX — which companies pay providers there.
